Constellation Pharmaceuticals Announces Second-Quarter and Six-Month 2018 Financial Results
Company raises an aggregate of $160 million in crossover financing in April and initial public offering (IPO) in July Company progressing its pipeline, including clinical programs CPI-1205 and CPI-0610 CAMBRIDGE, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- …
 
  
 
     
     
     
     
     
     
     
     
     
     
     
    